After the overexpression of BRM, the expression of almost all glycolytic genes (including PKM2), except fructose-1,6-bisphosphatase (FBP1), has been shown to increase in T24 bladder cancer cells, leading to increased glucose uptake. This evidence concerns the gene SMARCA2 and urinary bladder carcinoma.